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Abstract: Adherence to antiretroviral therapy reduces morbidity and mortality; however rates of non-adherence are
variable among women for unclear reasons. This study was a single-center qualitative analysis of interviews with 18
female HIV-positive non-adherent patients (defined by virologic failure) to explore psychosocial factors impacting
adherence. Factors identified were categorized as promoting, inhibiting or having no effect on adherence. Three themes,
characterized as social factors, illness factors and other societal pressures, were identified. Medical systems support,
family support and compliance for children were most commonly identified as promoting adherence, while psychiatric
comorbidities, lack of medical systems support and side effects were identified most often as inhibitors of adherence.
While stigma was frequently identified, it was not seen as a barrier to adherence. Enhancing relationships between
patients and their providers as well as their community support systems are critical avenues to pursue in improving
compliance. Interventions to promote compliance are important avenues of future research.
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INTRODUCTION
Adherence to Antiretroviral therapy (ART) reduces
morbidity and mortality, risk of viral resistance and
transmission to sexual partners and children. However, for
ART to be effective, adherence must be nearly complete, as
even above average levels of adherence (80-90%) are
associated with treatment failure in 50% of patients [1]. Nonadherent patients are noted to have an overall mortality risk
that is 3.8 times higher than that of adherent patients [2].
Adherence is therefore of critical importance to individual
patient outcomes as well as an overall public health concern
[3].
Only 88% of women living with HIV in the United States
are diagnosed, with 45% noting regular access to healthcare.
Of these, 32% have their disease well controlled on ART [4].
Reported rates of non-adherence to ART in women range
from 33-75%, a rate which is generally worse than reported
non-adherence rates in men [5-7]. Women have also been
found to have increased viral rebound following nonadherence episodes [8], making their non-adherence
behaviors potentially more morbid. Factors that have been
associated with non-adherence in women include depression
[1, 8-10], alcohol or substance abuse [1, 10, 11], medication
side effects [10, 12, 13], stigma [11, 13, 14], lack of social
support [1, 8], and poor patient-provider relationships [1, 9,
12, 13, 15]. While no demographic traits can reliably
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predict adherence [14], patient attitudes and beliefs have
been identified as important predictors of adherence [16].
Despite the advent of simpler ART regimens with better
side effect profiles, non-adherence still remains an important
public health concern [1, 13, 14]. We hypothesized that
women with less than optimal compliance with ART would
have important and potentially causal attitudes, beliefs and
unmet psychosocial needs that contributed to their nonadherence. This study was a single-center qualitative
analysis of interviews with female HIV-positive nonadherent patients. It was aimed at exploring both positive
and negative factors impacting adherence.
METHODS
This study was a qualitative analysis of individual patient
interviews. Using purposeful sampling [17], participants
were recruited from the Reading Health’s Center for Public
Health. Individuals were chosen for recruitment from the
185 female patients aged older than 18 who carried the
diagnosis of HIV infection. In order to identify a subset who
may have been non-adherent to medication regimens, we
selected the 105 records of those with any evidence of failure
of virologic suppression, defined by a viral load of >200
copies/ml in patients already prescribed antiviral medications
(as has been used by the HIV/AIDS bureau as a benchmark
of treatment failure [18].
Forty patients without either viable listed contact
information or could not be reached on successive calls were
further excluded, leaving 65 patients who were contacted
about our study and asked to participate in a one hour
2015 Bentham Open
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interview. Forty agreed to participate in the study and were
scheduled for formal consent and interview, and eighteen
patients completed the interview process. Participants were
compensated with a $25 gift card as compensation for their
time.
A semi-structured interview guide [17] was developed
from an extensive review of the literature to broach potential
barriers to adherence to therapy in women. A priori topic
areas [19] identified included economic issues (job security,
financial responsibilities, medication costs and co-pays),
family issues (including need to care for children and the
impact of support from loved ones), psychiatric issues,
substance abuse issues, educational factors (including formal
education and understanding of disease), healthcare logistics
(appointment timing, availability of transportation), trust in
providers and healthcare systems, overall health issues and
their impact on adherence, medication side effects, pill
burden issues, use of non-traditional medicines, spirituality
issues, and the patient’s own sense of responsibility for their
health.
Two female interviewers (including one physician (either
OF, AO) or one certified nurse practitioner (RF), along with
a communication specialist with extensive experience with
qualitative research (CF) performed all of the interviews.
One interview was with a Spanish-speaking only participant
and was performed with the aid of a certified female Spanish
interpreter, while the rest were performed in English. All
interviews were de-identified and recorded on audiotape and
transcribed by the hospital’s transcription service.
Table 1.

An initial inductive thematic analysis [20] of the data was
conducted independently by the four principal investigators
(OF, AO, AD, CF). Based on this initial review, a detailed
codebook was developed from the previously identified
themes and those detected from the initial thematic analysis.
All four investigators then re-reviewed the text and coded
the narrative. Finally, the four investigators reconvened to
reach agreement on the identified themes, and determined
whether the identified theme was helpful to compliance, a
barrier to compliance, or had no effect, with each decided by
consensus. The unit of analysis was a phrase, sentence or
paragraph of any particular section of narrative that was a
potential explanatory factor in non-adherence. Quotes were
corrected for grammar and changed (indicated by brackets)
to improve readability and to make the author anonymous.
This study was approved by the Reading Hospital
Institutional Review Board (IRB 009-12)
RESULTS
Eighteen females completed interviews. The average age
of participants was 47.7 (SD: 10.2) years. Ten participants
(56%) were Caucasian, five (28%) were Hispanic and three
(17%) were African-American. Six (33%) were currently
employed at time of the interview. Sixteen (89%) had
children, including eight (44%) who currently were caring
for those children. Twelve subjects (67%) had completed at
least a high school education, including five (28%) that had
schooling beyond high school. Eleven (61%) noted a past
history of substance abuse.

Total theme and subtheme counts.
Theme

Illness factors

Subtheme

Negative

Neutral

Positive

Total n

General sickness

9

2

0

11

Memory

7

0

0

7

pill burden

8

1

0

9

Psychiatric illness

18

4

0

22

Side effects

36

5

0

41

Substance abuse

11

5

0

16

89

17

0

106

Employment

6

5

1

12

Finances

12

2

0

14

Logistics

5

0

1

6

23

7

2

32

community support

1

0

12

13

compliance for children

0

0

21

21

family support

4

2

23

29

general life experiences

1

4

2

7

faith

1

3

6

10

medical systems support

26

0

43

69

stigma

3

23

0

26

36

32

107

175

Illness factors (n)

Other societal pressures

Other societal pressures (n)

Social factors

Social factors (n)

Factors Supporting and Inhibiting Compliance to HIV Medication Adherence in Women

The Open AIDS Journal, 2015, Volume 9

47

50
45
40
35
30
25
20
15

negative

10

neutral

5

positive

illness factors

Social factors

Logistics

Finances

Employment

stigma

medical systems support

faith

general life experiences

family support

compliance for children

community support

Substance abuse

Side effects

Psychiatric illness

pill burden

Memory

General sickness

0

other societal
pressures

Fig. (1). Bar chart of themes and subthemes showing impact on adherence.

Researchers examined the transcript and three emergent
themes (social factors, illness factors, and other societal
pressures) were derived after data saturation. The most
commonly represented theme had to do with social factors,
described 175 times by subjects (Table 1, Figs. 1, 2). We
identified seven subthemes to social factors, including
medical systems support (n=69), stigma (n=26), family
support (n=29), compliance for children (n=21), community
support (n=13), faith (n=10), general life experiences (n=7).
Under the theme of social support, support from the
medical system was the most commonly identified
subtheme. Perceived support from the medical system (or its
noted absence) was a critical factor in adherence and nonadherence. One subject who described her experience with
the medical system as very positive told us this:
“If it wasn’t for her <the clinic nurse
practitioner> I wouldn’t have complied at all.
It’s just really hard, I mean, you know, you’re
going to make me cry, it’s hard to find people
that you connect with, you know? She was my
caretaker, my friend, and my therapist… a

little bit of everything that sometimes you just
need.”
However, several described the opposite effect on
adherence from the healthcare system:
“<25 years ago>They put me on AZT. I took a
pill. I had had a really bad nose bleed, and I
called the nurse and told her “look,
whatever’s in this thing made my nose bleed”.
She told me that it didn’t, so I went and found
me a pill book and in the book it said AZT
could cause nose bleeds, and then I knew she
didn’t know what she was talking about and I
haven’t taken anything since.”
Almost every participant described a poignant story of
the stigma they felt as a result of their disease. Surprisingly,
their descriptions were matter-of-fact analyses that did not
seem to impact their adherence. One illustrative quote was:
“I’m not scared that <family and friends>
would find out, it wouldn’t affect me in any
way, I am who I am and if you can’t accept me
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Fig. (2). Schematic diagram of themes and subthemes.

for who I am, then the heck with you, right?
I’m going to live my life the longest I can.”
Personal family support was also identified as a generally
positive factor in adherence (23/29, 80% of comments), and
played a positive role with regards to living with HIV/AIDS.
One subject described it this way:
“…<My daughter>she takes care of me. When
I’m down and out that I can’t take care of
myself ...she makes sure I’m taking my
medications, she’s always there for me.”
Another said, “The devil’s around the corner
of the neighborhood every turn you take, so,
you gotta have your s--t a little bit together to
live down in the hood. If it wasn’t for my
family, it would be very difficult because I can
live without other people but not like my mom
or my sisters.”
Another important subtheme was identified in subjects
that cared for children. They nearly uniformly identified that
taking the medicine for the sake of their children was a
positive factor in their adherence. No one identified children
or child care as a barrier to adherence. Two illustrative
quotes were:

“… I remember when I was first diagnosed,
you know when people get that news,
everybody takes it differently. You want to go
into a deep depression, you feel hopeless, … I
was thinking of my sons’ graduation and how I
would like to be there to see them graduate.
You know, that gives you the motivation to
take care of yourself.”
“… When I was pregnant with him, I was on
the AZT and I felt so horrible on that, and that
was the medication I had tried before I even
got pregnant, and I couldn’t take it, but to help
my son, I took it. I stayed on it the whole
time.”
The second major theme identified in compliance had to
do with illness factors, identified 106 times. The vast
majority of comments in this theme (83%) were coded as
inhibitors of adherence, with the rest coded as neutral to
adherence. Subthemes identified included medication side
effects (n=41), psychiatric illness (n=22), general sickness
issues (n=11), substance abuse (n=16), pill burden (n=9), and
memory issues (n=7). Under illness factors, medication side
effects were a significant barrier to adherence in most that
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noted them (36/41, 88%). A quote that captured this
sentiment was:
“I was getting diarrhea and I drive almost an
hour to work every day so I just couldn’t take
the side effects. I can’t be showing up at work
and having a reaction at work, or on the way
to work, or if you’re late more than 2 or 3
times in one week then you get written up and
so if I had to go on the way to work I couldn’t
stop and then.”
Psychiatric illness was also cited as a major barrier to
compliance. One subject noted:
“When I’m in my depression and not
complying with my meds or my mental health
stuff, I just stay by myself. I don’t answer the
phone, the door, nothing. “
Substance abuse negatively impacted adherence in most
subjects who described this condition (11/16, 69%) with no
impact in the others (5/16, 31%) (Figs. 1, 2). One subject
told us:
“The only time I get in-in the absent mode is
when I’m back in my addiction mode because I
was told, ‘do not smoke crack, do Cocaine,
and take your med’s because I’ll make myself
resistant. So that’s the only time I don’t listen.
I gave up my nursing career for my addiction,
my marriages, … that was like my best friend,
my lover, you know, it was like nothing could
make me feel any better than that shot of Coke,
it was just like really good.”
Several (n=7) described having specific problems with
their short-term memory, and felt this negatively impacted
their adherence despite their desire to overcome it (Figs. 1,
2).
One participant described:
“I think that would just make my whole life
much easier if I could just not forget what I
was doing half the time. That has been my
major problem with my medication and my
adherence. From cooking to everything, you
know, you think about short term memory how
much it how it impacts everything from taking
medicine from going to appointments – I have
forgotten appointments. I’ve developed all
kinds of new gadgets because I just keep
putting stuff in there and have it putting up
timers and it’s very difficult. The number one
problem for adherence would be the memory.
“
The third major theme identified by the authors as
relevant to adherence was characterized as ‘other societal
pressures’. Subthemes for this included finances (n=14),
logistics (n=6) and employment/job issues (n=12). These
factors were nearly all perceived as barriers (23/32, 72%) or
neutral to adherence (7/32, 22%).
One illustrative quote that highlights patients’ struggles
with adherence related to work and finances was:
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“I am supposed to be making payments every
month, which I have not made, so I haven’t
even made a doctor appointment yet, it is hard
for me when it is busy at work because I do not
have any sick days, I can’t really ask for a day
off because I don’t have any sick days left. If it
were slow, then I could say, I really need to
get in to see a doctor, and again, they don’t
know that I am dealing with HIV.”
DISCUSSION
We found that relationships with providers, children,
family, and community were the most common factors with
a positive effect on adherence. Similar to our findings, other
authors noted positive association between strong patientprovider relationships that included open communication and
respect were associated with better adherence [7, 9, 11-13,
15, 21].
Conversely, we found that poor patient-provider
relationships were a major impediment to adherence. Other
authors report similar results, specifically noting that trust
issues and lack of perceived empathy from providers were
associated with non-adherence [1, 7, 9, 12, 13, 22].
While one author found negative relationship between
adherence and childcare responsibilities [7], our findings
mirrored those of Wood et al. [10], in which compliance for
the sake of dependent children was noted as a universally
positive factor in adherence. Similar to others, we identified
psychiatric issues, including alcohol and substance abuse [1,
10] and medication side effects [1, 7, 9, 10, 12] were
important barriers to adherence. While stigma from family,
providers and the general community was a nearly universal
theme represented in our interviews, we did not identify a
negative impact on adherence compared to other studies [7,
13, 14, 23].
This study used virologic failure as one of the major
inclusion criteria, allowing us to capture the voices of
women with an objectively documented treatment failure
measure associated with their subjective narratives of nonadherence. Our semi-structured interview method allowed us
to identify some patient-centered themes that often do not
emerge from studies using structured written surveys. The
major limitations of this work include that it was a single
center study on a small number of subjects, making it
difficult to generalize the results to other communities and
socioeconomic groups.
Identification of non-adherence is a critical part of care of
the patient with HIV. We echo the recommendations of
others who suggest that adherence should be directly
measured through readily available methods such as patient
surveys, pharmacy refill data [16], as well as objective
laboratory tests such as virologic failure for those on ART.
Depression screening should be performed at regular
intervals, and intervention resources should be provided at
the location of the screening, as depression has been found to
be a major barrier to adherence in multiple studies as
discussed above. When non-adherence is identified,
interventions should be patient-based and targeted to match
barriers identified in women’s daily lives, including coping
with side effects as well as substance and alcohol abuse [7,

50

The Open AIDS Journal, 2015, Volume 9

Fagbami et al.

14, 22]. As much as possible, continuity of care should be
maintained to establish and preserve confidence in the
medical system due to the huge impact this factor has been
shown to have on adherence. This will likely foster strong
patient provider relationships, hence impact adherence
positively. One future avenue of research could include the
effectiveness of interventions to help providers build rapport
with patients. Motivational interviewing techniques, voice
and text reminders and use of outreach resources [16],
including peer group support [12], all deserve further study
of their direct impact on adherence.
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